drugset / Trial / NCT04554615

Intensive Insulin Therapy as Therapeutic Strategy for Non-diabetic Hyperglycemia After Surgery in ICU

NCT04554615

Completed 86 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

The current study hypothesizes that the use of Intravenous intensive insulin therapy (IV-IIT) may be beneficial than IV conventional insulin therapy (IV-CIT) for improving the outcome of non-diabetic surgical patients had postoperative (PO) stress hyperglycemia (PSH).

Timeline

Start
2017-09-14
Primary completion
2018-03-03
Completion
2018-06-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 0.001 iu/kg Intravenous
Comparator Insulin Protein / enzyme biologic 50 iu Intravenous

Indications